Table 2.
Prevalence of Clinical Risk Factors for Chronic Disease, by Age and Sex, Among Alaska Native and American Indian People, EARTH Study, Alaska, 2004-2006
| Risk Factora | Men, % (95% CI) | |||
|---|---|---|---|---|
|
| ||||
| Age 18-39 y n = 742 | Age 40-59 y n = 610 | Age ≥60 y n = 150 | All Ages n = 1,502 | |
| Hypertension | 10 (8-12) | 14 (11-16) | 22 (15-29) | 13 (8-17) |
| Prehypertension | 55 (52-59) | 45 (41-49) | 38 (31-46) | 49 (46-53) |
| High total cholesterol | 31 (28-35) | 49 (45-53) | 48 (40-56) | 40 (36-44) |
| High LDL cholesterol | 27 (24-31) | 37 (33-41) | 37 (28-45) | 32 (27-36) |
| Low HDL cholesterol | 27 (24-31) | 20 (17-23) | 24 (17-30) | 24 (19-28) |
| High triglycerides | 25 (22-28) | 29 (26-33) | 29 (21-36) | 27 (22-31) |
| Abdominal obesity | 28 (25-31) | 41 (37-45) | 57 (49-65) | 36 (32-40) |
| BMI, kg/m2 b | ||||
| 25.0-29.9 | 34 (31-37) | 38 (34-41) | 36 (28-44) | 36 (32-40) |
| ≥30.0 | 29 (25-32) | 33 (29-37) | 43 (35-51) | 32 (28-36) |
| ≥40.0 | 5 (4-7) | 6 (4-7) | 6 (2-10) | 6 (1-10) |
| Fasting glucose, mg/dL | ||||
| 100-109 | 26 (23-30) | 31 (27-34) | 26 (19-33) | 28 (24-32) |
| 110-125 | 7 (6-9) | 13 (11-16) | 21 (15-28) | 11 (6-16) |
| >125 | 3 (2-5) | 7 (5-9) | 13 (7-18) | 6 (1-11) |
| Risk Factor a | Women, % (95% CI) | |||
|
| ||||
| Age 18-39 y n = 1,132 | Age 40-59 y n = 907 | Age ≥60 y n = 281 | All Ages n = 2,320 | |
| Hypertension | 5 (3-6) | 13 (11-16) | 29 (24-34) | 11 (7-15) |
| Prehypertension | 22 (19-24) | 32 (29-35) | 40 (34-45) | 28 (24-31) |
| High total cholesterol | 26 (23-29) | 51 (48-55) | 63 (57-69) | 40 (37-44) |
| High LDL cholesterol | 14 (12-16) | 28 (25-31) | 39 (33-45) | 22 (19-26) |
| Low HDL cholesterol | 13 (11-15) | 7 (5-9) | 11 (7-14) | 11 (7-14) |
| High triglycerides | 25 (23-28) | 32 (29-35) | 34 (28-39) | 29 (26-32) |
| Abdominal obesity | 65 (62-68) | 74 (71-77) | 80 (75-84) | 70 (68-72) |
| BMI, kg/m2 b | ||||
| 25.0-29.9 | 29 (26-31) | 30 (27-33) | 31 (26-37) | 29 (26-33) |
| ≥30.0 | 47 (44-50) | 51 (48-54) | 52 (46-58) | 49 (46-52) |
| ≥40.0 | 11 (9-13) | 11 (9-13) | 8 (4-11) | 11 (7-14) |
| Fasting glucose, mg/dL | ||||
| 100-109 | 19 (17-22) | 22 (19-25) | 28 (23-34) | 21 (18-25) |
| 110-125 | 6 (4-7) | 13 (11-15) | 18 (13-22) | 10 (6-14) |
| >125 | 3 (2-4) | 7 (5-8) | 7 (4-10) | 5 (1-9) |
Abbreviations: EARTH, Education and Research Towards Health; CI, confidence interval; LDL, low-density lipoprotein; HDL, high-density lipoprotein; BMI, body mass index.
a
Clinical risk factor categories based on recommendations from the National Cholesterol Education Program, the American Diabetes Association, and the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (11-13).
b
BMI categories are not mutually exclusive. All of the participants who appear in the ≥40 category also appear in the ≥30 category.